Transplant center directory

Our Stem Cell Transplant and Immunotherapy Program is the only adult academic program of its kind in the Washington, D.C. area, giving patients access to life-saving treatment options not otherwise available in our region. Our transplant specialists have extensive experience performing stem cell transplants and administering cellular immunotherapy. We work to provide a safe, effective, and comfortable experience for patients. Many patients who may have been turned away from other programs-either due to age, health, or other reasons-often find hope and treatment here.

This center has been performing allogeneic transplants since 2016 and has been an NMDP/Be The Match transplant center since May 2018.

This center's actual 1-year survival results are similar to the expected rate for this center.

The survival information we have for this center includes ONLY:

1. Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2019, 2020, 2021, and
2. Who had their transplant at a U.S. transplant center, and
3. Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 36 patients.

The actual 1-year survival of these patients is 72.2%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 66.5% and 91.6%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.

All diseases

Number of transplants by age reported from January 1, 2021 to December 31st, 2022 (includes marrow, PBSC and cord blood)

Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.